Jonathan Lai Selected Research

Jonathan Lai Research Topics

Disease

6	Pre-Eclampsia (Preeclampsia) 01/2022 - 01/2013
3	Infections 07/2023 - 01/2018
3	Hypertension (High Blood Pressure) 01/2022 - 01/2019
2	Neoplasms (Cancer) 01/2024 - 04/2013
2	Fetal Weight 01/2022 - 01/2021
2	Proteinuria 01/2022 - 01/2021
1	Psychomotor Agitation (Akathisia) 01/2024
1	Autoimmune Diseases (Autoimmune Disease) 01/2024
1	Pancytopenia 01/2024
1	Ankylosing Spondylitis 01/2024
1	Stomach Neoplasms (Stomach Cancer) 01/2024
1	Neoplasm Metastasis (Metastasis) 01/2024
1	Primary Myelofibrosis (Myelosclerosis) 07/2023
1	Breast Neoplasms (Breast Cancer) 07/2023
1	COVID-19 01/2023
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2023
1	Edema (Dropsy) 01/2022
1	Birth Weight (Birth Weights) 01/2022
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2022
1	Neuroinflammatory Diseases 01/2022
1	Starvation 01/2022
1	Fetal Growth Retardation (Intrauterine Growth Retardation) 01/2021
1	Cerebral Hemorrhage 01/2021
1	Fetal Death 01/2021
1	Hematoma 01/2021
1	Coma (Comas) 01/2019
1	Delirium 01/2019
1	Critical Illness (Critically Ill) 01/2019
1	Fatigue 06/2018
1	Treatment-Resistant Schizophrenia 06/2018
1	Autistic Disorder (Autism) 01/2018
1	Intussusception 12/2017
1	Neurilemmoma (Schwannoma) 11/2017
1	Polyps 11/2017
1	Thromboembolism 05/2017
1	Pain (Aches) 05/2017
1	Necrosis 05/2017
1	Protein C Deficiency 05/2017
1	Tuberous Sclerosis (Bourneville's Disease) 04/2017

Drug/Important Bio-Agent (IBA)

4	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2022 - 01/2013
2	Proteins (Proteins, Gene)FDA Link 01/2023 - 01/2022
2	Tyrosine (L-Tyrosine)FDA Link 01/2021 - 01/2014
1	Valproic Acid (Depakote)FDA LinkGeneric 01/2024
1	Triglycerides (Triacylglycerol)IBA 01/2024
1	Ferritins (Ferritin)IBA 01/2024
1	GlucocorticoidsIBA 01/2024
1	NivolumabIBA 01/2024
1	Immune Checkpoint InhibitorsIBA 01/2024
1	S-Phase Kinase-Associated Proteins (Skp1 Protein)IBA 01/2023
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2023
1	Phosphates (Orthophosphate)IBA 01/2023
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2023
1	AMP-Activated Protein KinasesIBA 01/2023
1	Phosphotransferases (Kinase)IBA 01/2023
1	Beclin-1IBA 01/2023
1	Cell-Free Nucleic AcidsIBA 01/2023
1	Mechanistic Target of Rapamycin Complex 1IBA 01/2023
1	Sirolimus (Rapamycin)FDA Link 01/2023
1	Leukocyte Elastase (Neutrophil Elastase)IBA 01/2023
1	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023
1	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 01/2023
1	Antiviral Agents (Antivirals)IBA 01/2023
1	Complement Membrane Attack Complex (Membrane Attack Complex)IBA 01/2023
1	Chloroquine (Aralen)FDA LinkGeneric 01/2023
1	Thromboplastin (Tissue Factor)IBA 01/2023
1	phosphatidylinositol 3-phosphateIBA 01/2023
1	Hydroxychloroquine (Plaquenil)FDA LinkGeneric 01/2023
1	Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA 01/2023
1	Peroxidase (Myeloperoxidase)IBA 01/2023
1	Biomarkers (Surrogate Marker)IBA 01/2022
1	LipidsIBA 01/2022
1	diazonaphthalenedisulfonic acid (NDS)IBA 01/2022
1	A 19IBA 01/2022
1	Influenza Vaccines (Influenza Vaccine)FDA Link 06/2021
1	Collagenases (Collagenase)FDA Link 01/2021
1	Dexmedetomidine FDA Link 01/2019
1	BenzodiazepinesIBA 01/2019
1	MelatoninIBA 01/2019
1	Clozapine (Clozaril)FDA LinkGeneric 06/2018
1	Methylphenidate (Ritalin)FDA LinkGeneric 06/2018
1	AntibodiesIBA 01/2018
1	mahuang-tangIBA 01/2018
1	Monoclonal AntibodiesIBA 01/2018
1	VimentinIBA 11/2017
1	Protein CIBA 05/2017
1	Vitamin K FDA Link 05/2017
1	Warfarin (Coumadin)FDA LinkGeneric 05/2017
1	AnticoagulantsIBA 05/2017
1	Dabigatran FDA Link 05/2017
1	RivaroxabanIBA 05/2017
1	trans-sodium crocetinate (crocetin)IBA 04/2017

Therapy/Procedure

2	Therapeutics 01/2024 - 05/2017
2	Immunotherapy 01/2024 - 07/2023
1	Contraindications 01/2024
1	Diet Therapy (Therapy, Diet) 01/2022
1	Artificial Respiration (Mechanical Ventilation) 01/2019
1	Length of Stay 01/2019
1	Conservative Treatment 12/2017
1	Operative Surgical Procedures 12/2017
1	Cautery 11/2017